To further investigate the role of adenosine A2a receptors in gefiitnib-resistance to NSCLC, we generated another gefitinib-resistant clone by exposing gefitinib to gefitinib-sensitive NSCLC cells, HCC827 cells. Here, ADORA2A is linked to non-small cell lung carcinoma.